Skip to content
Search

Latest Stories

‘Harmful’ chewed tobacco products face clampdown

Cancer-causing chewed tobacco products are facing a clampdown 16 years after scientists warned of their dangerous contents, a government statement said.

The department of health and social care (DHSC) has told parliament that it plans to regulate ‘most harmful tobacco products’ used by half a million British south Asians who consume betel quid, paan or gutkha -- a mixture of ingredients, including betel nut, herbs, spices and often tobacco, usually wrapped in a betel leaf.


Research has shown that using smokeless tobacco raises the risk of mouth cancer and oesophageal (food pipe) cancer.

Studies have also found that betel itself can raise the risk of cancer, so chewing betel quid without tobacco, which is popular among south Asian women, is still harmful.

In 2006, government chemists found that many of these products contained high levels of carcinogens.

In a paper which analysed the results professors Ann McNeill and Robert West said chewed tobacco was “a major cause of oral cancer” and urged the government to set product standards. However, the government has resisted that and other calls to create standards.

In a recent statement, the government’s former drugs tsar, Professor David Nutt, accused DHSC of “reverse racism” over “lethal” south Asian chewed tobacco.

Professor Nutt has now written about the problem to Javed Khan who has been commissioned by DHSC to write a report on the health disparities caused by tobacco which will be published on 22 April.

The statement further said that the report will influence the department’s forthcoming Tobacco Control Plan, which is due to be published later this year.

According to the Office for National Statistics, smoking rates across the country have been falling steadily over the past 20 years and cigarette use dropped from 15.8 per cent in 2019 to 14.5 per cent in 2020.

However, there are still six million smokers in England. Tobacco remains the single largest cause of preventable death and 64,000 people died from conditions related to smoking in 2019.

NHS community pharmacies are a great place for patients to receive stop smoking advice and support as well as any lifestyle advice.

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
NHS pharmacy funding not enough 2025: £3.073B deal with £1.99B gap fuels reform debate.

Funding alone isn’t going to be enough to save community pharmacy

Photo credit: gettyimages

New funding contract ‘not enough’ to release the sector from financial blackhole

After almost a year without an agreement, a new funding contract for community pharmacy was finally announced yesterday (31 March).

The settlement raises the baseline annual funding for the Community Pharmacy Contractual Framework (CPCF) in 2025/26 to £3.073 billion, with an additional £215 million secured to continue Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less